The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Business update

30 Apr 2007 07:49

ViaLogy PLC30 April 2007 Date: 30 April 2007On behalf of: ViaLogy plc ("ViaLogy" or "the Company") For immediate release ViaLogy PLC Business Update Vialogy SPMTM selected by US Department of Defence for joint experiments todevelop Joint Forces Protection and Base Security Systems London, April 30, 2007 -- ViaLogy PLC (LSE: VIY), announces that its Americansubsidiary, ViaLogy LLC, has been chosen by the US Department of Defence (DoD)to participate in joint experiments to support next-generation Joint ForceProtection Advanced Security (JFPASS) Joint Capabilities TechnologyDemonstration (JCTD). ViaLogy was selected to provide a Command and Controlplatform for the experiments. Recent DoD studies have found that current technologies, as employed, do notprovide a comprehensive, integrated and sustainable Joint Force Protectioncapability. The goal of JFPASS is to address these shortcomings with a potential$60 million combined services project to begin in 2008. The JFPASS JCTD is a joint services (Army, Navy, Air Force and Marines)initiative for integrating tactical systems, sensors and security personnel toprotect forces and over 600 facilities in the US and overseas. NATO and othercoalition partners have similar needs for base and force protection globally. ViaLogy will be providing its SPMTM (Sensor Policy Manager) product for theinternet protocol-enabled sensors and systems to accurately and immediatelyinterpret and disseminate information to pre-selected destinations. The lack ofsuch an effective interoperability between systems has previously been asignificant problem for both the military and public sectors. At a recent integration assessment supporting JFPASS JCTD in the Space and NavalWarfare Systems Centre (SPAWAR), San Diego, CA, ViaLogy successfullydemonstrated interoperability between two disparate operators, NorthropGrumman's Tactical Asset Security System (TASS) and the Joint BattlespaceCommand and Control Station (JBC2S) for unmanned systems. ViaLogy has alsointegrated a Lightweight Chemical Detector (LCD) from Smiths Detection tovalidate the IP-based plug-and-play capabilities of SPMTM. The LCD is part ofthe soldiers' hand-held equipment and is used for checking cargo, personnel orbuildings for chemical warfare agents. ViaLogy's SPMTM product provides a sensor-based policy engine for the rapiddetection, analysis and transmission of information. It exploits internetprotocol and patented signal processing to deliver interoperability to sensor,video and network sub-systems. Of major importance to potential users of SPMTM are its reliability,adaptability and affordability. "The product is designed for scaleableimplementation involving hundreds and even thousands of sensors," said Dr.Sandeep Gulati, ViaLogy's Chief Technology Officer. "JFPASS requirements presentan ideal opportunity for SPMTM. The technology thrives on the unexpected and, inthe event of a major incident, plays a vital role in detection and effectivedamage control." Previously, as NASA's Jet Propulsion Laboratory PrincipalScientist for sensor fusion, Dr. Gulati was extensively involved with sensorintensive command and control systems. ViaLogy CEO, Mr. Shah Talukder stated: "Higher demand for commercialoff-the-shelf products will shift procurement from project-centric toproduct-centric acquisition of technology. This will drive down project costsand timelines as it does in private sector procurement." Mr. Talukder who, prior to joining ViaLogy, developed the vision, strategy androad map for Cisco's Interoperability and Collaboration System (IPICS), added: "By delivering comprehensive sensor, video and tactical interoperability in anetwork-centric platform we believe SPM product will be able to meet JFPASS JCTDrequirements and play an integral part in the joint forces security project." For further information please contact: ViaLogy Shah Talukder, CEO - US +1 626-296-6337Terry Bond, Chairman - UK & Europe +44 (0)20 2869 7014 Redleaf CommunicationsEmma Kane / Samantha Robbins +44 (0)20 7822 0200 Seymour Pierce Limited (NOMAD)Mark Percy +44 (0)20 7107 8000 About ViaLogy: Network Centric Signal Processing. ViaLogy is a leading innovator of network-centric, real-time signal processingplatforms for sensor applications. ViaLogy is currently deploying and designingcomputational systems, powered by its patented technologies, for applications inlife sciences, public safety and security, surveillance, defense andgeoseismology. Vialogy focuses on market driven problems where automation,timeliness, quality and reliability of information processing are essential.ViaLogy's core competency incorporates rapidly and accurately detecting weaksignals buried in high noise background and clutter. This technology can beemployed to solve problems involving sensor integration and information overloadchallenges involving video, telephony and control sensors, as well as forenhancement of numerous signal processing applications. For more information,visit our website at www.vialogy.com. Except for statements of historical fact, the information presented hereinconstitutes forward-looking statements within the meaning of the PrivateSecurities Litigation Reform Act of 1995. Such forward-looking statementsinvolve known and unknown risks, uncertainties and other factors which may causethe actual results, performance or achievements of the company to be materiallydifferent from any future results, performance or achievements expressed orimplied. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
6th Apr 20204:40 pmRNSSecond Price Monitoring Extn
6th Apr 20204:36 pmRNSPrice Monitoring Extension
27th Mar 20203:00 pmRNSIssue of Share Options
25th Mar 20207:00 amRNSContract manufacturing agreement for COVID-19 test
16th Mar 20204:41 pmRNSSecond Price Monitoring Extn
16th Mar 20204:36 pmRNSPrice Monitoring Extension
13th Mar 202011:51 amRNSHolding(s) in Company
10th Mar 20207:00 amRNSAcquisition of French distribution channel
17th Feb 20207:00 amRNSCE Marking Technical File submission
14th Feb 202011:00 amRNSMedilink Award win for Outstanding Achievement
14th Feb 20207:00 amRNSTGA approves DPYD for sale in Australia
5th Dec 201912:10 pmRNSThe Healthcare+ Expo Taiwan
2nd Dec 20197:00 amRNSHalf-year Report
29th Nov 201912:05 pmRNSBionow Double Award Win
28th Nov 20197:00 amRNSOpening of New Facilities and Corporate HQ
15th Nov 20197:00 amRNSPrivate Investor Presentation
12th Nov 201910:12 amRNSNotice of Results
6th Nov 20191:52 pmRNSCapital Markets Day
1st Nov 20197:00 amRNSDirector/PDMR Shareholding
31st Oct 20197:00 amRNSLaunch of Yourgene FlexT Analysis Software
30th Oct 20197:00 amRNSIssue of Share Options
15th Oct 20197:00 amRNSAmerican Society of Human Genetics Annual Meeting
14th Oct 20197:00 amRNSHalf year trading update
1st Oct 20197:00 amRNSPrivate Investor Presentation
26th Sep 20197:00 amRNSCE-IVD Certification renewal
18th Sep 20197:00 amRNSLaunch of DPYD chemotoxicity diagnostic assay
17th Sep 20195:50 pmRNSResult of AGM
17th Sep 20197:00 amRNSAGM Statement
20th Aug 20197:00 amRNSNotice of AGM
19th Aug 201910:35 amRNSChange of Registered Office
16th Aug 20193:49 pmRNSHolding(s) in Company
16th Aug 20199:06 amRNSDirectorate Change
12th Aug 20197:00 amRNSAmendment to Share Options
1st Aug 20197:00 amRNSDirector/PDMR Shareholding
29th Jul 20197:00 amRNSAppointment of Director
10th Jul 20197:00 amRNSFinal Results, Business Update and Director Change
27th Jun 20197:00 amRNSNotice of Results
24th Jun 20197:00 amRNSYourgene participates in key global conferences
3rd Jun 20197:01 amRNSDirector's dealing
3rd Jun 20197:00 amRNSIssue of Share Options
9th May 20194:07 pmRNSDirector's dealing
9th May 20197:00 amRNSDirectors' dealing & warrant extension
1st May 20198:05 amRNSTotal Voting Rights
26th Apr 20195:12 pmRNSHolding(s) in Company
26th Apr 20195:01 pmRNSHolding(s) in Company
25th Apr 20194:40 pmRNSCompletion of Acquisition
18th Apr 20197:00 amRNSResults of Placing and Subscription
17th Apr 20194:50 pmRNSAppointment of Sole Corporate Broker
17th Apr 20194:48 pmRNSProposed Acquisition, Placing & Subscription
8th Apr 20197:00 amRNSFull-year Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.